Citadel Advisors’s Stevanato STVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,000
Closed -$40.8K – 14986
2025
Q1
$40.8K Buy
2,000
+1,300
+186% +$27.7K ﹤0.01% 12524
2024
Q4
$15.3K Sell
700
-2,000
-74% -$40.1K ﹤0.01% 13362
2024
Q3
$54K Buy
2,700
+1,200
+80% +$24.2K ﹤0.01% 11820
2024
Q2
$27.5K Sell
1,500
-4,300
-74% -$100K ﹤0.01% 12353
2024
Q1
$186K Buy
5,800
+3,100
+115% +$94.4K ﹤0.01% 10432
2023
Q4
$73.7K Buy
2,700
+1,000
+59% +$28.8K ﹤0.01% 11327
2023
Q3
$50.5K Buy
1,700
+1,200
+240% +$37.6K ﹤0.01% 11749
2023
Q2
$16.2K Buy
+500
New +$14K ﹤0.01% 12907
2023
Q1
– Sell
-11,000
Closed -$198K – 15485
2022
Q4
$198K Buy
+11,000
New +$182K ﹤0.01% 10156

Other funds holding STVN

Citadel Advisors's STVN Position: Q2 2026 in Review

Citadel Advisors reduced its Stevanato (STVN) stake by 14% in Q2 2026, selling an estimated $1.06M and leaving 369,225 shares worth $6.67M. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Citadel Advisors first reported a position in STVN in Q3 2021 and has held it in 15 quarters since. The position peaked at $14.1M in Q3 2021. 125 funds tracked by Wall St. Rank hold STVN as of Q2 2026.

  • Citadel Advisors held 369,225 shares of Stevanato worth $6.67M as of Q2 2026.
  • Citadel Advisors sold 62,538 Stevanato shares in Q2 2026, an estimated $1.06M.
  • Stevanato made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4230 holding.
  • Citadel Advisors first reported a position in Stevanato in Q3 2021 and has held it in 15 quarters since.
  • Citadel Advisors's Stevanato position peaked at $14.1M in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Stevanato as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.